Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 17.70
-0.10 (-0.56%)
At close: Nov 28, 2025
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 353.31 million as of November 28, 2025. Its market cap has increased by 146.03% in one year.
Market Cap
353.31M
Enterprise Value
362.06M
Revenue
55.93M
Ranking
n/a
PE Ratio
15.92
Stock Price
17.70
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 353.31M, an increase of 14.32%. That is a compound annual growth rate of 0.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 353.31M | 102.87% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | 38.37M | -66.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.32B |
| Novartis AG | 200.48B |
| Lonza Group AG | 38.63B |
| Galderma Group AG | 37.98B |
| Alcon | 31.37B |
| Sandoz Group AG | 24.43B |
| Straumann Holding AG | 14.61B |
| Sonova Holding AG | 11.93B |